122 related articles for article (PubMed ID: 37886827)
21. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
[TBL] [Abstract][Full Text] [Related]
22. Antipeptide Immunocapture with In-Sample Calibration Curve Strategy for Sensitive and Robust LC-MS/MS Bioanalysis of Clinical Protein Biomarkers in Formalin-Fixed Paraffin-Embedded Tumor Tissues.
Zheng N; Taylor K; Gu H; Santockyte R; Wang XT; McCarty J; Adelakun O; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2020 Nov; 92(21):14713-14722. PubMed ID: 33047598
[TBL] [Abstract][Full Text] [Related]
23. Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood.
Steuer AE; Poetzsch M; Koenig M; Tingelhoff E; Staeheli SN; Roemmelt AT; Kraemer T
J Chromatogr A; 2015 Feb; 1381():87-100. PubMed ID: 25596763
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
Lai RS; Chen CC; Lee PC; Lu JY
Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194
[TBL] [Abstract][Full Text] [Related]
25. Immunoassay of neuron-specific enolase (NSE) and serum fragments of cytokeratin 19 (CYFRA 21.1) as tumor markers in small cell lung cancer: clinical evaluation and biological hypothesis.
Giovanella L; Piantanida R; Ceriani L; Bandera M; Novario R; Bianchi L; Roncari G
Int J Biol Markers; 1997; 12(1):22-6. PubMed ID: 9176714
[TBL] [Abstract][Full Text] [Related]
26. Measurement of human serum unconjugated estriol without derivatization using liquid chromatography-tandem mass spectrometry candidate reference method and compared with two immunoassays.
Huang X; Zhang Q; Zheng S; Wang J; Han L; Lin H; Ke P; Zhuang J; Cao ZT
Anal Bioanal Chem; 2018 Sep; 410(24):6257-6267. PubMed ID: 30006726
[TBL] [Abstract][Full Text] [Related]
27. Quantification of serum C-peptide by isotope-dilution liquid chromatography-tandem mass spectrometry: enhanced detection using chemical modification and immunoaffinity purification.
Kinumi T; Mizuno R; Takatsu A
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():138-42. PubMed ID: 24607695
[TBL] [Abstract][Full Text] [Related]
28. CYFRA 21-1 in non-small cell lung cancer--standardisation and application during diagnosis.
Pavićević R; Bubanović G; Franjević A; Stancić-Rokotov D; Samarzija M
Coll Antropol; 2008 Jun; 32(2):485-98. PubMed ID: 18756899
[TBL] [Abstract][Full Text] [Related]
29. CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy.
Ebert W; Muley T
Anticancer Res; 1999; 19(4A):2669-72. PubMed ID: 10470217
[TBL] [Abstract][Full Text] [Related]
30. Selective quantification of the 22-kDa isoform of human growth hormone 1 in serum and plasma by immunocapture and LC-MS/MS.
Sleumer B; van Faassen M; Vos MJ; Bischoff R; Kema IP; van de Merbel NC
Anal Bioanal Chem; 2022 Aug; 414(20):6187-6200. PubMed ID: 35838770
[TBL] [Abstract][Full Text] [Related]
31. Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer.
Park J; Yang JS; Jung G; Woo HI; Park HD; Kim JW; Huh W; Ko JW; Kim H; Cho JY; Lee SY
J Proteomics; 2013 Dec; 94():302-10. PubMed ID: 24120528
[TBL] [Abstract][Full Text] [Related]
32. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum.
Ishikawa E; Yokoyama Y; Chishima H; Kuniyoshi O; Sato I; Nakaya N; Nakajima H; Kimura M; Hakamata J; Suehiro N; Nakada H; Ikemura S; Jibiki A; Kawazoe H; Muramatsu H; Suzuki S; Nakamura T
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 May; 1199():123245. PubMed ID: 35436724
[TBL] [Abstract][Full Text] [Related]
34. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma.
Huang MS; Jong SB; Tsai MS; Lin MS; Chong IW; Lin HC; Hwang JJ
Respir Med; 1997 Mar; 91(3):135-42. PubMed ID: 9135852
[TBL] [Abstract][Full Text] [Related]
35. An antibody-free LC-MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma.
Pratt MS; van Faassen M; Remmelts N; Bischoff R; Kema IP
Anal Bioanal Chem; 2021 Mar; 413(8):2035-2044. PubMed ID: 33569646
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the docetaxel concentration in human plasma measured with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and a nanoparticle immunoassay and clinical applications of that assay.
Geng C; Li P; Chen X; Yuan G; Guo N; Liu H; Zhang R; Guo R
Biosci Trends; 2017 May; 11(2):202-208. PubMed ID: 28420860
[TBL] [Abstract][Full Text] [Related]
37. A selective and sensitive UPLC-ESI-MS/MS method for quantification of Pegylated Interferon Alfa-2b in human serum using signature peptide-based quantitation.
Bob Kusuma M; Kashibhatta R; Jagtap SS; Nadawade V; Adsul S; Moorkoth S; Bhat K; Mody R; Vithala P
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1180():122883. PubMed ID: 34438247
[TBL] [Abstract][Full Text] [Related]
38. Soluble cytokeratin-19 and E-selectin biomarkers: their relevance for lung cancer detection when tested independently or in combinations.
Swellam M; Ragab HM; Abdalla NA; El-Asmar AB
Cancer Biomark; 2008; 4(1):43-54. PubMed ID: 18334733
[TBL] [Abstract][Full Text] [Related]
39. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
Jourdil JF; Lebert D; Gautier-Veyret E; Lemaitre F; Bonaz B; Picard G; Tonini J; Stanke-Labesque F
Anal Bioanal Chem; 2017 Feb; 409(5):1195-1205. PubMed ID: 27826630
[TBL] [Abstract][Full Text] [Related]
40. A Rapid and Simple Liquid-Chromatography-Tandem Mass Spectrometry Method for Measuring 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 in Human Serum: Comparison with Two Automated Immunoassays.
Lee S; Kim JH; Kim SA; Sun YS; Lee A; Park SJ; Kim YT; Lee KR; Kim YJ
Ann Clin Lab Sci; 2016 Dec; 46(6):645-653. PubMed ID: 27993879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
